Intuitive Surgical, Inc. (ISRG) Financials
PeriodQ3 FY2026
Published
Intuitive Surgical reported revenue of $3.05 billion for Q3 FY2026, the quarter ended September 30, 2026, up 21.7% from a year earlier, with instruments and accessories, systems and services all growing. Net income attributable to Intuitive was $522.8 million, or $1.49 per diluted share, down 25.8% from $704.4 million, because the quarter carried a $450 million charge for its agreement to settle a hospital antitrust class action, which still needs court approval. On the company's own non-GAAP basis, which excludes the charge, diluted earnings per share were $3.00, up 25.0% from $2.40.
| Metric | Amount | vs. year ago |
|---|---|---|
| Revenue | $3,048,700,000 | up 21.7% |
| Net income | $522,800,000 | down 25.8% |
| Diluted EPS | $1.49 | down 23.6% |
| Antitrust settlement charge | $450,000,000 | |
| Non-GAAP diluted EPS | $3.00 | up 25.0% |
Company details
| Name | Intuitive Surgical Inc |
|---|---|
| Ticker | ISRG |
| CIK | 0001035267 |
| Exchange | Nasdaq |
| State | California |
| Incorporation | Delaware |
| SIC | 3842 |
| Office | Industrial Applications and Services |
| Industry | Orthopedic, Prosthetic & Surgical Appliances & Supplies |
| Latest period covered | Q3 FY2026, ended 2026-09-30, 10-Q, accession 0001035267-26-000071 |
| Fiscal year end | 12/31 (MM/DD) |
| Next expected filing | 10-K around 2027-02-02 (predicted) |
Data files
- Financial statementsPage Annual financial statements plus the latest quarter: income statement, balance sheet, cash flow. Actual dollars, actual shares. Sourcing notes and uncertainties included, plus a figure_sources block linking each figure the filing tags to the line that prints it.
- 10-K and 10-Q summaryPage Qualitative synthesis of the latest 10-K + 10-Q: business, risk factors (quarter-over-quarter changes flagged), MD&A, legal proceedings, subsequent events.
- 8-K filings and eventsPage Digest of material 8-K filings: earnings headlines, management changes, capital-return and financing actions, governance. SEC accession numbers cited throughout.
FAQ · Intuitive Surgical Q3 FY2026
How much revenue did Intuitive Surgical report in Q3 FY2026?
Intuitive Surgical reported revenue of $3.05 billion for Q3 FY2026, the quarter ended September 30, 2026. That is up 21.7% from $2.51 billion in the same quarter a year earlier.
Why did Intuitive Surgical's earnings fall in Q3 FY2026?
Intuitive Surgical's net income attributable to the company fell to $522.8 million in Q3 FY2026, down 25.8% from $704.4 million a year earlier, and diluted earnings per share fell to $1.49 from $1.95. The decline reflects a $450 million operating-expense charge, recorded in the quarter, for settling a hospital antitrust class action, while revenue was up 21.7% from a year earlier.
What is Intuitive Surgical's antitrust class action settlement?
Intuitive Surgical agreed after the quarter to make a one-time payment of $450 million to settle the hospital class action known as In re: da Vinci Surgical Robot Antitrust Litigation, with agreed injunctive relief and no admission of liability. The company recorded the full amount as an operating-expense charge and a liability for the quarter ended September 30, 2026, and the settlement still needs preliminary and final court approval.
What was Intuitive Surgical's non-GAAP EPS in Q3 FY2026?
Intuitive Surgical reported non-GAAP diluted earnings per share of $3.00 for Q3 FY2026, up 25.0% from $2.40 a year earlier, compared with GAAP diluted earnings per share of $1.49. The company's non-GAAP measure excludes items including the antitrust settlement charge, share-based compensation and amortization of intangible assets.
Where can I get Intuitive Surgical, Inc. (ISRG) financial data in machine-readable form?
Ticker Scout publishes Intuitive Surgical, Inc.'s financial statements as JSON at https://tickerscout.ai/isrg/financials.json, free, with no API key and no signup. The 10-K and 10-Q narrative and the 8-K events digest are published as Markdown at https://tickerscout.ai/isrg/narrative.md and https://tickerscout.ai/isrg/events.md. Intuitive Surgical, Inc.'s SEC CIK is 0001035267. Every figure cites the SEC accession number it came from, so it can be checked against sec.gov.
When does Intuitive Surgical, Inc. (ISRG) next file with the SEC?
Intuitive Surgical, Inc. (ISRG) is expected to file its next Form 10-K with the SEC on or around February 2, 2027. That date is a projection rather than a company-announced date: it is derived from Intuitive Surgical, Inc.'s own filing history with the SEC, by taking the date the company filed the same fiscal period a year earlier and adding 52 weeks. The most recent periodic report on file is the 10-Q for Q3 FY2026, the period ended 2026-09-30, SEC accession 0001035267-26-000071.
Related companies
How this page was built
This page was built from Intuitive Surgical, Inc.'s own filings with the SEC, read one at a time, and nothing on it is taken from a pre-tagged dataset, a data vendor or another website. The figures are on the company's own fiscal calendar and in actual dollars, as the filings report them. Where the filings do not support a figure, the record says so instead of reporting a zero; this period names two such gaps.
A single company files thousands of pages with the SEC in a year, and no two companies file them the same way, so the reading and the assembly here are done by AI rather than by rules that break on the differences. Every pass is then audited back against the filings it came from before the page is published, and anything the filings do not support is left out and named rather than filled in. AI can still make mistakes. That is why the accession numbers are printed: the filing is the authority, and this page is a route to it.
Published by Ticker Scout, an independent publisher of company filings data. About Ticker Scout · Disclaimer
Data extracted from SEC filings (accession numbers cited in each file). The undated URLs hold the latest period and are replaced in place each quarter; every period also stays published at its own dated URL, which never changes. Free to cite with attribution: Ticker Scout (tickerscout.ai). Not investment advice, see the Disclaimer.